Larotaxel
- Generic Name
- Larotaxel
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C45H53NO14
- CAS Number
- 156294-36-9
- Unique Ingredient Identifier
- TWQ8K8A81Y
- Background
Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 34
- Registration Number
- NCT00327743
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath